WILLIAM BRADSHAW: Open Payments
NPI 1760076657 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 62 payments from 19 companies in 2025. Trend: 2023 $1,115 · 2024 $867 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| Novartis Pharmaceuticals Corporation | 15 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83 |
| Amgen Inc. | 4 | $70 |
| Corcept Therapeutics | 4 | $69 |
| ABBVIE INC. | 3 | $66 |
| Novo Nordisk Inc | 3 | $53 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $41 |
Products named: LEQVIO, FARXIGA, Kerendia, JARDIANCE, Korlym, Auvelity, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
